Abstract
We conducted a retrospective analysis to determine if both α1-antitrypsin serum level and phenotype need be studied when evaluating children for α1-AT deficiency. We collected data from patients less than 19 years old who had both serum α1-AT level and phenotype determined over a 9-year period (January 1992–December 2000). Eighty-eight patients were identified and 15 had the PiZZ phenotype. The serum α1-AT level was below normal (normal 85–215 mg/dl) in all 15 PiZZ patients. Seventy-two of 73 non-PiZZ patients had normal or above normal serum levels. The sensitivity of the serum α1-AT level was 100%, and the specificity was 99%. The serum α1-AT level had a positive predictive value of 94% and a negative predictive value of 100%. We conclude that serum α1-AT levels are highly predictive of the PiZZ phenotype. Determination of the serum α1-AT level alone should be the initial test when evaluating for α1-AT deficiency.
Similar content being viewed by others
REFERENCES
Teckman JH, Qu D, Perlmutter DH: Molecular pathogenesis of liver disease in α1-antitrypsin deficiency. Hepatology 24:1504–1516, 1996
Norman MR, Mowat AP, Hutchison DCS: Molecular basis, clinical consequences and diagnosis of alpha-1 antitrypsin deficiency. Ann Clin Biochem 34:230–246, 1997
Carrell RW, Lomas DA: Alpha1-antitrypsin deficiency—a model for conformational diseases. N Engl J Med 346:45–53, 2002
Sveger T: The natural history of liver disease in α1-antitrypsin deficient children. Acta Paediatr Scand 77:847–851, 1988
Larsson C: Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 204:345–351, 1978
Sveger T: Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 294:1316–1321, 1976
O'Brien ML, Buist NRM, Murphey WH: Neonatal screening for alpha1-antitrypsin deficiency. J Pediatr 92:1006–1010, 1978
Silverman EK, Miletich JP, Pierce JA, Sherman LA, Endicott SK, Broze GJ Jr, Campbell EJ: Alpha-1-antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 140:961–966, 1989
Ogushi F, Hubbard RC, Vogelmeier C, Fells GA, Crystal RG: Risk factors for emphysema: cigarette smoking is associated with a reduction in the association rate constant of lung α1-antitrypsin for neutrophil elastase. J Clin Invest 87:1060–1065, 1991
Buist AS, Burrows B, Cohen A, Crystal RG, Fallat RJ, Gadek JE, Turino GM: Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. Am Rev Respir Dis 140:1494–1497, 1989
Primhak RA, Tanner MS: Alpha-1 antitrypsin deficiency. Arch Dis Child 85:2–5, 2001
Ward AM, Cooper EH, Turner R, Anderson JA, Neville AM: Acute-phase reactant protein profiles: An aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer 35:170–178, 1977
Lamy Y, Ibrahim S, Lomanto C, Dombrowiecki A: Sequential changes of α1-antitrypsin after surgical trauma. Clin Chim Acta 89:387–391, 1978
Child JA, Roberts BE, Illingworth S, Cooper EH: Acute phase reactant proteins in chronic leukaemia. Biomedicine 27:188–190, 1977
Beyeler C, Banks RE, Bird HA: Polymorphonuclear elastase-α1-proteinase inhibitor (elastase-α1 antitrypsin) in patients with rheumatic diseases: Influence of disease activity. J Rheumatol 27:15–19, 2000
Carlson J, Eriksson S: α1-antitrypsin and other acute phase reactants in liver disease. Acta Med Scand 207:79–83, 1980
El-Kassimi FA, Warsy AS, Uz-Zaman A, Pillai DK: Alpha 1-antitrypsin serum levels in widespread bronchiectasis. Respir Med 83:119–121, 1989
Sharp HL, Bridges RA, Krivit W, Freier EF: Cirrhosis associated with alpha-1-antitrypsin deficiency: A previously unrecognized inherited disorder. J Lab Clin Med 73:934–939, 1969
Lieberman J, Mittman C: Dynamic response of α1-antitrypsin variants to diethylstilbestrol. Am J Hum Genet 25:610–617, 1973
Gadek JE, Fulmer JD, Gelfand JA, Frank MM, Petty TL, Crystal RG: Danazol-induced augmentation of serum α1-antitrypsin levels in individuals with marked deficiency of this antiprotease. J Clin Invest 66:82–87, 1980
Wewers MD, Gadek JE, Keogh BA, Fells GA, Crystal RG: Evaluation of danazol therapy for patients with PiZZ alpha-1-antitrypsin deficiency. Am Rev Respir Dis 134:476–480, 1986
Wewers MD, Brantly ML, Casolaro MA, Crystal RG: Evaluation of tamoxifen as a therapy to augment alpha-1-antitrypsin concentrations in Z homozygous alpha-1-antitrypsin-deficient subjects. Am Rev Respir Dis 135:401–402, 1987
Brantly ML, Wittes JT, Vogelmeier CF, Hubbard RC, Fells GA, Crystal RG: Use of a highly purified α1-antitrypsin standard to establish ranges for the common normal and deficient α1-antitrypsin phenotypes. Chest 100:703–708, 1991
Fagerhol MK: The genetics of alpha-1-antitrypsin and its implications. Postgrad Med J 52 Suppl 2:73–83, 1976
Turino GM, Barker AF, Brantly ML, Cohen AM, Connelly RP, Crystal RG, Eden E, Schluchter MD, Stoller JK: Clinical features of individuals with Pi*SZ phenotype of α1-antitrypsin deficiency. Am J Respir Crit Care Med 154:1718–1725, 1996
Odievre M, Martin J-P, Hadchouel M, Alagille D: Alpha1-antitrypsin deficiency and liver disease in children: phenotypes, manifestations, and prognosis. Pediatrics 57:226–231, 1976
Mahadeva R, Chang WW, Dafforn TR, Oakley DJ, Foreman RC, Calvin J, Wight DG, Lomas DA: Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis. J Clin Invest 103:999–1006, 1999
Pittschieler K, Massi G: Liver involvement in infants with PiSZ phenotype of α1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr 15:315–318, 1992
Pittschieler K: Heterozygotes and liver involvement. Acta Paediatr Suppl 393:21–23, 1994
Bell H, Schrumpf E, Fagerhol MK: Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease. Scand J Gastroenterol 20:835–842, 1985
Hodges JR, Millward-Sadler GH, Barbatis C, Wright R: Heterozygous MZ alpha1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 304:557–560, 1981
Vecchio FM, Fabiano A, Orsini G, Ragusa D, Massi G: Alpha-1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults. Digestion 27:100–104, 1983
Carlson J, Eriksson S: Chronic ‘cryptogenic’ liver disease and malignant hepatoma in intermediate alpha1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody. Scand J Gastroenterol 25:788–792, 1990
Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W: High prevalence of viral infection in adults with homozygous and heterozygous alpha1-antitrypsin deficiency and chronic liver disease. Ann Intern Med 117:641–645, 1992
Elzouki AN, Hulcrantz R, Stal P, Befrits R, Eriksson S: Increased PiZ gene frequency for α1 antitrypsin in patients with genetic haemochromatosis. Gut 36:922–926, 1995
Vennarecci G, Gunson BK, Ismail T, Hubscher SG, Klly DA, McMaster P, Elias E: Transplantation for end stage liver disease related to alpha 1 antitrypsin. Transplantation 61:1488–1495, 1996
Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK: Increased risk of chronic liver failure in adults with heterozygous α1-antitrypsin deficiency. Hepatology 28:1058–1063, 1998
Vaughan L, Lorier MA, Carrell RW: α1-Antitrypsin microheterogeneity isolation and physiological significance of isoforms. Biochim Biophys Acta 701:339–345, 1982
Cook PJL: The genetics of α1-antitrypsin: a family study in England and Scotland. Ann Hum Genet 38:275–287, 1975
Whitehouse DB, Lovegrove JU, Hopkinson DA: Variation in alpha-1-antitrypsin phenotypes with penicillamine therapy. Clin Chim Acta 179:109–116, 1989
Whitehouse DB, Lovegrove JU, Mieli-Vergani G, Mowat AP, Hopkinson DA: 'sZ like' α1-antitrypsin phenotypes in Pi ZZ children with liver disease. Ann Hum Genet 58:11–17, 1994
Attenburrow AA: Modification of the α1-antitrypsin phenotype in neonatal hepatitis. Arch Dis Child 60:378–379, 1985
Sveger T: Screening for alpha1-antitrypsin deficiency. Acta Paediatr Suppl 393:18–20, 1994
Rights and permissions
About this article
Cite this article
Steiner, S.J., Gupta, S.K., Croffie, J.M. et al. Serum Levels of α1-Antitrypsin Predict Phenotypic Expression of the α1-Antitrypsin Gene. Dig Dis Sci 48, 1793–1796 (2003). https://doi.org/10.1023/A:1025411515683
Issue Date:
DOI: https://doi.org/10.1023/A:1025411515683